Status:
COMPLETED
Effects of Combined Natural Molecules on Metabolic Syndrome in Menopausal Women
Lead Sponsor:
Lo.Li.Pharma s.r.l
Conditions:
Menopause
Climacteric Syndrome
Eligibility:
FEMALE
45-60 years
Brief Summary
The study collected retrospective data from the assumption of combined natural molecules in menopausal women with metabolic syndrome
Eligibility Criteria
Inclusion
- menopause
- diagnosis of metabolic syndrome
Exclusion
- pharmacologically-induced menopause
- hormonal therapies
- sensitizing insulin therapies
- cancer patient or ex-cancer patient
Key Trial Info
Start Date :
September 30 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 15 2023
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT06057896
Start Date
September 30 2022
End Date
August 15 2023
Last Update
November 8 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
SCCAL
Naples, Italy